---
figid: PMC6702832__OMCL2019-4654206.007
figtitle: The NFE2L2 pathway in fibroblasts
organisms:
- NA
pmcid: PMC6702832
filename: OMCL2019-4654206.007.jpg
figlink: /pmc/articles/PMC6702832/figure/fig7/
number: F7
caption: Modulation of the NFE2L2 pathway in fibroblasts. The NFE2L2 pathway in fibroblasts
  can be either activated or inhibited depending on the administered compound. ROS,
  eotaxin, and curcumin mediate the release of NFE2L2 from the inhibitor KEAP1. Flavone
  via the activation of MAPK1 facilitates the phosphorylation of NFE2L2. In addition,
  Mrp1 removes glutathione conjugates to drugs in a NFE2L2-dependent manner. However,
  TGFβ signaling inhibits NFE2L2 activity which can be counteracted by the administration
  of SFN. Finally, the fibroblast caveolae can also inhibit NFE2L2 function preventing
  the expression of antioxidant enzymes that require the translocation of a NFE2L2
  transcription factor to the nucleus and its interaction with MAF.
papertitle: 'Signaling Pathways, Chemical and Biological Modulators of Nucleotide
  Excision Repair: The Faithful Shield against UV Genotoxicity.'
reftext: F. Kobaisi, et al. Oxid Med Cell Longev. 2019;2019:4654206.
year: '2019'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9515529
figid_alias: PMC6702832__F7
figtype: Figure
organisms_ner:
- Homo sapiens
redirect_from: /figures/PMC6702832__F7
ndex: 4d1eaa97-de95-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6702832__OMCL2019-4654206.007.html
  '@type': Dataset
  description: Modulation of the NFE2L2 pathway in fibroblasts. The NFE2L2 pathway
    in fibroblasts can be either activated or inhibited depending on the administered
    compound. ROS, eotaxin, and curcumin mediate the release of NFE2L2 from the inhibitor
    KEAP1. Flavone via the activation of MAPK1 facilitates the phosphorylation of
    NFE2L2. In addition, Mrp1 removes glutathione conjugates to drugs in a NFE2L2-dependent
    manner. However, TGFβ signaling inhibits NFE2L2 activity which can be counteracted
    by the administration of SFN. Finally, the fibroblast caveolae can also inhibit
    NFE2L2 function preventing the expression of antioxidant enzymes that require
    the translocation of a NFE2L2 transcription factor to the nucleus and its interaction
    with MAF.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - SFN
  - REXO2
  - CCL11
  - CCL24
  - CCL26
  - TGFB1
  - TGFB2
  - TGFB3
  - MRPL1
  - MRPL2
  - MRPL3
  - MRPL4
  - MRPL9
  - MRPL10
  - MRPL11
  - MRPL12
  - MRPL13
  - MRPL14
  - MRPL15
  - MRPL16
  - MRPL17
  - MRPL18
  - MRPL19
  - MRPL20
  - MRPL21
  - MRPL22
  - MRPL23
  - MRPL24
  - MRPL27
  - MRPL28
  - MRPL30
  - MRPL32
  - MRPL33
  - MRPL34
  - MRPL35
  - MRPL36
  - MRPL37
  - MRPL38
  - MRPL39
  - MRPL40
  - MRPL41
  - MRPL42
  - MRPL43
  - MRPL44
  - MRPL45
  - MRPL46
  - MRPL47
  - MRPL48
  - MRPL49
  - MRPL50
  - MRPL51
  - MRPL52
  - MRPL53
  - MRPL54
  - MRPL55
  - MRPL57
  - CD9
  - MDM4
  - ABCC1
  - MSH3
  - NFE2L2
  - MAPK14
  - MAF
  - MAFA
  - MAFB
  - MAFF
  - MAFG
  - MAFK
  - EPHB2
  - MAPK1
  - MAPK3
  - SFN
  - GSH
  - Curcumin
  - Flavone
---
